Montco neurology group at odds with Independence Blue Cross, Highmark over coverage for new Alzheimer’s drug

The decision on whether to cover a new drug shown to slow the progression of Alzheimer’s has put a group of Montgomery County neurologists at odds with two Pennsylvania health insurers.
Click here to view original post